ATXS: Astria Therapeutics Inc Sotuvga nisbatan narx
Astria Therapeutics (ATXS) irsiy angioedemaga qarshi kurashish uchun antitanalarni tijoratlashtira oladimi? Kam uchraydigan patologiyalar uchun klinik sinovlarning ko'p tarmoqli tabiati xatarlarni minimallashtiradi. AI va robototexnika qo'llanilishi dori vositalari sintezini tezlashtiradi, bu esa median P/S ko'rsatkichi bilan tasdiqlanadi. 997.10 qiymati ushbu ko'rsatkichning so'nggi ma'lumotlarini ko'rsatadi, u narxning savdoga nisbati ko'rsatkichini aniqlash orqali bozor ma'lumotlaridan hissiy shovqinlarni olib tashlaydi.
Astria Pharma (ATXS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Jamlagan qarzning kapitalga nisbati Astria Therapeutics|ATXS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Astria Corp|ATXS - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Astria Pharma|ATXS - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Astria Therapeutics|Oraliq qoplash koeffitsiyenti astriatx.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
ATXS - Sof daromad|Kelajakdagi sof foyda Astria Therapeutics|ATXS - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori Astria Therapeutics Inc|ATXS - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Astria Pharma|ATXS - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Astria Therapeutics|ATXS - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi astriatx.com|ATXS - Joriy yilda bir aksiya uchun foyda o'sishi|Kelgusi yil uchun bir aksiya uchun sof foydaning o'zgarishi prognozi Astria Therapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:ATXS, astriatx.com
Emitent ishonchliligini tekshirishda, P/S koeffitsiyenti biznesning bozor qiymatini uning daromadlariga nisbatan baholash imkonini beradi va sotuvlarning har bir birligi uchun to'langan premiumni aniqlaydi. Operatsion richagga ega bo'lmagan holda tadqiqot va ishlanmalar (R&D) xarajatlari yukini ko'targan Astria Therapeutics (ATXS) uchun ushbu metrika juda muhimdir, chunki narx/sotuvlar koeffitsiyenti tendentsiyasi dori vositalari tijoratlashtirilishidan oldin faqat kelgusi daromadlar bo'yicha spekulyativ bozor kutganlarini aks ettiradi.
Raqobatdosh kompaniyalar
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|PTGX - P/S multiplikatori|Immunovant, Inc. (IMVT) - Narxning daromadga nisbati|KNSA - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati GRFS|ADPT (Adaptive Biotech) - Kapitalizatsiyaning sotish hajmiga nisbati|Narxning daromadga nisbati Celldex (CLDX)|AUPH (Aurinia Corp) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BCRX (BioCryst)|Narx/daromad koeffitsiyenti veratx.com (VERA)|Dianthus Therapeutics, Inc. - P/S multiplikatori|PHVS - P/S multiplikatori|ABCL (AbCellera Biologics Inc) - Kapitalizatsiyaning daromadga nisbati|Tourmaline - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PGEN|PHAR (pharming.com) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori NKTR|UPB (Upstream Bio, Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|Immunome Bio (IMNM) - Sotuvga nisbatan narx|GOSS - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati KALV (kalvista.com)|SEPN: P/S multiplikatori|Pieris Pharma (PVLA) - P/S multiplikatori|Narxning daromadga nisbati Savara Corp|Rigel Corp - Narxning sotuvga nisbati|P/S multiplikatori ANAB|ENGN - Sotuvga nisbatan narx|RAPT Therapeutics - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Aerovate Therapeutics, Inc. JBIO|ACRS: Kapitalizatsiyaning daromadga nisbati|Kyverna Therapeutics, Inc - Kapitalizatsiyaning sotish hajmiga nisbati|TLSA: P/S multiplikatori|CABA - Narx/daromad koeffitsiyenti|VTYX (Ventyx Biosciences, Inc.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Theratechnologies, Inc. (THTX)|Narxning daromadga nisbati Avalo Therapeutics Inc. (AVTX)|Narx/daromad koeffitsiyenti Eledon Pharmaceuticals, Inc|P/S multiplikatori AGEN (Agenus)|P/S multiplikatori climbbio.com CLYM|ZURA: Kapitalizatsiyaning daromadga nisbati|aTyr Pharma Inc - Kapitalizatsiyaning sotish hajmiga nisbati|ADAG (adagene.com) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiya va daromad nisbati IMA|Narxning daromadga nisbati Shattuck Labs Inc|Equillium Bio (EQ) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Connect Biopharma (CNTB)|IMUX: Narxning sotuvga nisbati|P/S multiplikatori ATRA (Atara Bio)|Bozor kapitallashuvining daromadga nisbati IFRX|X4 Pharmaceuticals - P/S multiplikatori|ACET - P/S multiplikatori|celularity.com (CELU) - Narxning daromadga nisbati|INmune Bio Inc - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Barinthus Bio|Kapitalizatsiyaning daromadga nisbati Kezar Life Sciences Inc (KZR)|P/S multiplikatori SABS|P/S multiplikatori akaritx.com (AKTX)|Enlivex Therapeutics Ltd. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati QTTB|GeoVax Labs Inc - P/S multiplikatori|Narx/daromad koeffitsiyenti Edesa Biotech Corp EDSA|iBio, Inc. (IBIO) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Carisma Therapeutics Inc.|Narxning daromadga nisbati XTL Biopharmaceuticals Ltd.|Kapitalizatsiyaning daromadga nisbati Bolt Bio (BOLT)|Kapitalizatsiyaning daromadga nisbati HCWB (HCW Biologics Inc.)|P/S multiplikatori aptevotherapeutics.com (APVO)|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX: Kapitalizatsiya va daromad nisbati|GRI Bio - P/S multiplikatori|Sotuvga nisbatan narx XORTX Therapeutics Inc|HIND: P/S multiplikatori|Revelation Biosciences Corp (REVB) - P/S multiplikatori|Narxning daromadga nisbati Indaptus Therapeutics|scinai.com (SCNI) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati CALI (CalciMedica, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati AFMD|Narxning daromadga nisbati Allakos ALLK|Bozor kapitallashuvining daromadga nisbati HOOK|IGM Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti iteostherapeutics.com ITOS|OCEA: P/S multiplikatori|TC BioPharm (Holdings) Plc (TCBP) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati THRD
